148 related articles for article (PubMed ID: 19520551)
1. In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
Cordeiro Rde A; Brilhante RS; Rocha MF; Medrano DJ; Monteiro AJ; Tavares JL; de Lima RA; de Camargo ZP; Sidrim JJ
Int J Antimicrob Agents; 2009 Sep; 34(3):278-80. PubMed ID: 19520551
[TBL] [Abstract][Full Text] [Related]
2. Large-Scale Evaluation of
Thompson GR; Barker BM; Wiederhold NP
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096163
[TBL] [Abstract][Full Text] [Related]
3. In vitro inhibitory effect of antituberculosis drugs on clinical and environmental strains of Coccidioides posadasii.
de Aguiar Cordeiro R; Brilhante RS; Rocha MF; Fechine MA; Camargo ZP; Sidrim JJ
J Antimicrob Chemother; 2006 Sep; 58(3):575-9. PubMed ID: 16867997
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of caspofungin, amphotericin B and azoles against Coccidioides posadasii strains from Northeast, Brazil.
Cordeiro RA; Brilhante RS; Rocha MF; Fechine MA; Costa AK; Camargo ZP; Sidrim JJ
Mycopathologia; 2006 Jan; 161(1):21-6. PubMed ID: 16389480
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of antituberculosis drugs and azoles in vitro against Histoplasma capsulatum var. capsulatum.
Cordeiro Rde A; Marques FJ; Brilhante RS; Rocha de Castro E Silva K; Mourão CI; Caetano EP; Fechine MA; Ribeiro JF; Castelo-Branco Dde S; de Lima RA; Mesquita JR; Monteiro AJ; Rocha FA; Rocha MF; Sidrim JJ
Antimicrob Agents Chemother; 2011 Sep; 55(9):4482-4. PubMed ID: 21690286
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro antifungal activity of isoniazid-derived hydrazones against Coccidioides posadasii.
Cordeiro Rde A; de Melo CV; Marques FJ; Serpa R; Evangelista AJ; Caetano EP; Mafezoli J; de Oliveira Mda C; da Silva MR; Bandeira Tde J; Moreira JL; Brilhante RS; Rocha MF; Sidrim JJ
Microb Pathog; 2016 Sep; 98():1-5. PubMed ID: 27334293
[TBL] [Abstract][Full Text] [Related]
7. Cotrimoxazole enhances the in vitro susceptibility of Coccidioides posadasii to antifungals.
Cordeiro Rde A; Astete-Medrano DJ; Marques FJ; Andrade HT; Perdigão Neto LV; Tavares JL; de Lima RA; Patoilo KK; Monteiro AJ; Brilhante RS; Rocha MF; de Camargo ZP; Sidrim JJ
Mem Inst Oswaldo Cruz; 2011 Dec; 106(8):1045-8. PubMed ID: 22241131
[TBL] [Abstract][Full Text] [Related]
8. Ciprofloxacin shows synergism with classical antifungals against Histoplasma capsulatum var. capsulatum and Coccidioides posadasii.
Brilhante RS; Caetano EP; Sidrim JJ; Cordeiro RA; Camargo ZP; Fechine MA; Lima RA; Castelo Branco DS; Marques FJ; Mesquita JR; Lima DT; Monteiro AJ; Rocha MF
Mycoses; 2013 May; 56(3):397-401. PubMed ID: 23205615
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.
Cuenca-Estrella M; Gomez-Lopez A; Buitrago MJ; Mellado E; Garcia-Effron G; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2006 Jun; 50(6):2248-50. PubMed ID: 16723597
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Skóra M; Bulanda M; Jagielski T
Antimicrob Agents Chemother; 2015 Sep; 59(9):5827-9. PubMed ID: 26100698
[TBL] [Abstract][Full Text] [Related]
11. Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets.
Carrillo-Muñoz AJ; Quindós G; del Valle O; Santos P; Giusiano G; Ezkurra PA; Estivill MD; Casals JB
Chemotherapy; 2008; 54(1):38-42. PubMed ID: 18073469
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus Species.
Gao L; Ding X; Liu Z; Wu Q; Zeng T; Sun Y
Antimicrob Agents Chemother; 2016 Jun; 60(6):3813-6. PubMed ID: 26976874
[TBL] [Abstract][Full Text] [Related]
13. Generation of mutants in Candida albicans with reduced susceptibility to caspofungin: influence on other antifungal products.
Soler L; Rodriguez JC; Belda S; Cremades R; Ruiz-Garcia M; Lopez P; Royo G
J Chemother; 2010 Aug; 22(4):283-4. PubMed ID: 20685636
[No Abstract] [Full Text] [Related]
14. In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
Nishi I; Sunada A; Toyokawa M; Asari S; Iwatani Y
J Infect Chemother; 2009 Feb; 15(1):1-5. PubMed ID: 19280292
[TBL] [Abstract][Full Text] [Related]
15. Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.
Cuenca-Estrella M; Gomez-Lopez A; Garcia-Effron G; Alcazar-Fuoli L; Mellado E; Buitrago MJ; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2005 Mar; 49(3):1232-5. PubMed ID: 15728937
[TBL] [Abstract][Full Text] [Related]
16. Synergistic activities of three triazoles with caspofungin against Candida glabrata isolates determined by time-kill, Etest, and disk diffusion methods.
Kiraz N; Dag I; Yamac M; Kiremitci A; Kasifoglu N; Oz Y
Antimicrob Agents Chemother; 2010 May; 54(5):2244-7. PubMed ID: 20194697
[TBL] [Abstract][Full Text] [Related]
17. In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
Li H; Lu Q; Wan Z; Zhang J
Int J Antimicrob Agents; 2010 Jun; 35(6):550-2. PubMed ID: 20202797
[TBL] [Abstract][Full Text] [Related]
18. Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.
O'Shaughnessy EM; Meletiadis J; Stergiopoulou T; Demchok JP; Walsh TJ
J Antimicrob Chemother; 2006 Dec; 58(6):1168-76. PubMed ID: 17071635
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
Najafzadeh MJ; Saradeghi Keisari M; Vicente VA; Feng P; Shamsian SA; Rezaei-Matehkolaei A; de Hoog GS; Curfs-Breuker I; Meis JF
Antimicrob Agents Chemother; 2013 Dec; 57(12):6395-8. PubMed ID: 24100491
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the in vitro kinetic activity of caspofungin against Candida glabrata.
Nagappan V; Boikov D; Vazquez JA
Antimicrob Agents Chemother; 2010 Jan; 54(1):522-5. PubMed ID: 19841143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
